Brushing up on the science of obesity with Rhythm Pharmaceuticals’ CEO
David Meeker describes his company’s focus on the melanocortin-4 receptor pathway and elaborates on data presented this week for hypothalamic obesity.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
Popular
#1. Pfizer’s CEO on Q2 earnings.
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square
bottom of page